Breaking News Instant updates and real-time market news.

ZGNX

Zogenix

$52.66 /

+0.81 (+1.56%)

08:16
03/19/19
03/19
08:16
03/19/19
08:16

Zogenix enters distribution agreement for Fintepla in Japan with Nippon Shinyaku

Zogenix announced that it has entered into an exclusive distribution agreement with Nippon Shinyaku for the commercialization of its lead product candidate, Fintepla, in Japan. Zogenix is developing Fintepla internationally for the treatment of Dravet syndrome and Lennox-Gastaut syndrome, or LGS. Under the terms of the agreement, Nippon Shinyaku will receive exclusive commercial rights to Fintepla in Japan. In exchange, Zogenix will receive payments totaling $20M, a major portion of which was paid at signing and the remainder of which will be paid over the next two years. Zogenix will also be eligible to receive future regulatory and sales-based milestone payments. In addition, Zogenix will supply product to Nippon Shinyaku and receive a tiered transfer price based on Zogenix's manufacturing costs, as well as the annual net sales of Fintepla in Japan. Zogenix will retain responsibility for completing its global clinical development programs for Fintepla, including those already underway to support Zogenix's planned submissions of new drug applications in Japan for Dravet syndrome and LGS.

  • 04

    Apr

ZGNX Zogenix
$52.66 /

+0.81 (+1.56%)

03/12/19 Mizuho
Zogenix remains a top pick for 2019 at Mizuho
03/06/19 Piper Sandler
Departure of Gottlieb brings some biopharma uncertainty, says Piper Jaffray
02/22/19 Guggenheim
Zogenix initiated with a Buy at Guggenheim
02/06/19 Piper Sandler
Piper confident in Fintepla approval, reiterates Overweight on Zogenix

TODAY'S FREE FLY STORIES

Earnings
Avangrid reports Q4 EPS 74c, consensus 76c » 16:22
02/25/20
02/25
16:22
02/25/20
16:22
AGR

Avangrid

$56.34 /

-0.245 (-0.43%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
WW reports Q4 EPS 42c, consensus 38c » 16:22
02/25/20
02/25
16:22
02/25/20
16:22
WW

WW

$34.88 /

-2.01 (-5.45%)

Reports Q4 revenue $333M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Penumbra sees FY20 revenue $635M-$645M, consensus $651.96M » 16:21
02/25/20
02/25
16:21
02/25/20
16:21
PEN

Penumbra

$176.17 /

-8.11 (-4.40%)

FY20 revenue guidance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Akcea Therapeutics reports Q4 EPS 86c, consensus $1.11 » 16:21
02/25/20
02/25
16:21
02/25/20
16:21
AKCA

Akcea Therapeutics

$17.09 /

+0.29 (+1.73%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Castlight Health reports Q4 adjusted EPS (5c), consensus (3c) » 16:21
02/25/20
02/25
16:21
02/25/20
16:21
CSLT

Castlight Health

$1.29 /

-0.035 (-2.64%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Morgan Stanley metals/commodities analysts hold analyst/industry conference call » 16:21
02/25/20
02/25
16:21
02/25/20
16:21

Global Commodity…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Abraxas Petroleum receives updated Nasdaq non-compliance notice » 16:21
02/25/20
02/25
16:21
02/25/20
16:21
AXAS

Abraxas Petroleum

$0.20 /

-0.0122 (-5.70%)

On August 28, 2019,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Penumbra reports Q2 EPS 27c, consensus 20c » 16:20
02/25/20
02/25
16:20
02/25/20
16:20
PEN

Penumbra

$176.17 /

-8.11 (-4.40%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
GW Pharmaceuticals reports Q4 EPS (7c), two estimates (75c) » 16:20
02/25/20
02/25
16:20
02/25/20
16:20
GWPH

GW Pharmaceuticals

$116.85 /

-4.02 (-3.33%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Salesforce CEO Benioff says 'our Q4 and FY20 results were phenomenal' » 16:20
02/25/20
02/25
16:20
02/25/20
16:20
CRM

Salesforce

$181.65 /

-4.26 (-2.29%)

"Our Q4 and FY20…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Heico backs FY20 revenue growth view of 6%-8% » 16:20
02/25/20
02/25
16:20
02/25/20
16:20
HEI

Heico

$113.32 /

-5.62 (-4.73%)

Raises FY20 net income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Closing CBOE SPX and VIX Index summary for February 25th » 16:20
02/25/20
02/25
16:20
02/25/20
16:20
VIX

Volatility Index S&P 500 Options

$0.00 /

+ (+0.00%)

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Iovance says manufacturing facility on track for production in 2022 » 16:20
02/25/20
02/25
16:20
02/25/20
16:20
IOVA

Iovance Biotherapeutics

$31.51 /

+6.82 (+27.62%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Huya downgraded to Neutral on cost inflation at Goldman Sachs » 16:19
02/25/20
02/25
16:19
02/25/20
16:19
HUYA

Huya

$19.31 /

-0.16 (-0.82%)

, BILI

Bilibili

$26.75 /

-0.17 (-0.63%)

, BABA

Alibaba

$205.74 /

-0.46 (-0.22%)

, TCEHY

Tencent

$0.00 /

+ (+0.00%)

, JD

JD.com

$38.84 /

-0.52 (-1.32%)

, TCOM

Trip.com Group

$30.14 /

-1.11 (-3.55%)

, PDD

Pinduoduo

$32.78 /

-0.36 (-1.09%)

, TME

Tencent Music

$12.33 /

+0.11 (+0.90%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Jazz Pharmaceuticals sees FY20 adjusted EPS $12.50-$13.40, consensus $17.05 » 16:19
02/25/20
02/25
16:19
02/25/20
16:19
JAZZ

Jazz Pharmaceuticals

$127.51 /

-3.3 (-2.52%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Craft Brew shareholders approve proposed deal with Anheuser-Busch » 16:19
02/25/20
02/25
16:19
02/25/20
16:19
BREW

Craft Brew

$16.15 /

-0.005 (-0.03%)

, BUD

AB InBev

$66.88 /

-2.48 (-3.58%)

Craft Brew Alliance, Inc.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Adamas Pharmaceuticals reports Q4 EPS (83c), consensus (85c) » 16:19
02/25/20
02/25
16:19
02/25/20
16:19
ADMS

Adamas Pharmaceuticals

$4.76 /

-0.48 (-9.16%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Lumentum withdraws from OFC 2020, cites spread of coronavirus » 16:18
02/25/20
02/25
16:18
02/25/20
16:18
LITE

Lumentum

$77.72 /

-2.3 (-2.87%)

Lumentum announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Heico reports Q1 EPS 89c including 34c in benefits, consensus 75c » 16:18
02/25/20
02/25
16:18
02/25/20
16:18
HEI

Heico

$113.32 /

-5.62 (-4.73%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Alarm.com sees 2020 adjusted EPS $1.48-$1.49, consensus $1.46 » 16:18
02/25/20
02/25
16:18
02/25/20
16:18
ALRM

Alarm.com

$44.79 /

-1.49 (-3.22%)

Sees 2020 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Potbelly sees 8-10 total shop closures in FY20 » 16:18
02/25/20
02/25
16:18
02/25/20
16:18
PBPB

Potbelly

$5.40 /

-0.32 (-5.59%)

In FY20 sees 8-10 total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Matador Resources sees FY20 oil production 16M-16.5M bbl » 16:18
02/25/20
02/25
16:18
02/25/20
16:18
MTDR

Matador

$10.87 /

-1.325 (-10.87%)

Sees FY20 total oil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Infinera sees Q1 EPS (18c) plus/minus 3c, consensus (9c) » 16:17
02/25/20
02/25
16:17
02/25/20
16:17
INFN

Infinera

$7.90 /

-0.2 (-2.47%)

Sees Q1 revenue $325M +/-…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Potbelly sees FY20 adjusted EBITDA between $20.5M-$25.5M » 16:17
02/25/20
02/25
16:17
02/25/20
16:17
PBPB

Potbelly

$5.40 /

-0.32 (-5.59%)

Sees FY20 cost of goods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Alarm.com sees Q1 SaaS and license revenue $89.9M-$90.1M  16:17
02/25/20
02/25
16:17
02/25/20
16:17
ALRM

Alarm.com

$44.79 /

-1.49 (-3.22%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.